What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis

Yvonne L Luigjes-Huizer; Nina Møller Tauber; Gerry Humphris; Nadine A. Kasparian; Wwt Lam; Sophie Lebel; Sébastien Simard; Allan Ben Smith; Robert Zachariae; Yati Afiyanti; Katy Bell; José A. E. Custers; Niek J. de Wit; Peter Fisher; Jacqueline Galica; Sheila N. Garland; Charles W. Helsper; Mette Moustgaard Jeppesen; Jianlin Liu; Roxana Mititelu; Evelyn M. Monninkhof; Lahiru Russell; Josée Savard; Anne Speckens; Sanne Jasperine van Helmondt; Sina Vatandoust; Nicholas Zdenkowski; Marije L. van der Lee

doi:10.1002/pon.5921

Abstract

This is the authors' abstract. We don't add key points for this paper.

FCR affects a considerable number of cancer survivors and patients. It is therefore important that healthcare providers discuss this issue with their patients and provide treatment when needed. Further research is needed to investigate how best to prevent and treat FCR and to identify other factors associated with FCR. The protocol was prospectively registered (PROSPERO CRD42020142185).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Luigjes-Huizer et al. (2022) studied this question.

synapsesocial.com/papers/69dac336ed2e131d3c68443f https://doi.org/10.1002/pon.5921

View Full Paper

Ask AI

Bookmark

Share

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis

Abstract

Discussion

Cite This Study

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis

Abstract

Discussion

Cite This Study

Keep reading

Keep reading